Page last updated: 2024-09-05

temocillin and Intra-Abdominal Infections

temocillin has been researched along with Intra-Abdominal Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carryn, S; Dugernier, T; Laterre, PF; Mouton, JW; Muller, AE; Tulkens, PM; Van de Velde, S; Wittebole, X1
Alexandre, K; Cattoir, V; Chau, F; Fantin, B; Guérin, F; Lefort, A; Massias, L1

Trials

1 trial(s) available for temocillin and Intra-Abdominal Infections

ArticleYear
Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Illness; Enterobacteriaceae Infections; Female; Humans; Intraabdominal Infections; Male; Middle Aged; Organization and Administration; Penicillins; Prospective Studies; Respiratory Tract Infections

2015

Other Studies

1 other study(ies) available for temocillin and Intra-Abdominal Infections

ArticleYear
Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producing Escherichia coli.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteremia; Bacterial Proteins; beta-Lactamases; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Female; Injections, Subcutaneous; Intraabdominal Infections; Mice; Microbial Sensitivity Tests; Penicillins; Plasma; Spleen; Survival Analysis; Treatment Outcome

2016